Dr. Parihar earned a BS in Pharmacy from the Institute of Chemical Technology (formerly
UDCT) at Mumbai University and earned a PhD in Pharmaceutical Sciences from the University
of Louisiana at Monroe in Monroe, LA. He completed his post-doctoral fellowship in
Medicinal Chemistry at the University of Kansas in Lawrence, KS. Dr. Parihar is a
registered pharmacist in Georgia.
Prior to joining the PCOM School of Pharmacy Dr. Parihar held faculty positions at Lake Erie College of Osteopathic Medicine (LECOM) School of Pharmacy in Erie, PA and Long Island University School of Pharmacy in Brooklyn, NY.
PhD (Pharmaceutical Sciences), The University of Louisiana at Monroe, Monroe, LA,
Bachelor of Pharmacy (B.Pharm), University of Bombay, Bombay, India, 1999
o PHAR150G Biochemistry (course coordinator)
o PHAR212G Integrated Therapeutics II (Medicinal Chemistry section)
o PHAR241G Infectious Disease I (course coordinator) (Medicinal Chemistry section)
o PHAR311G Integrated Therapeutics IV (Medicinal Chemistry section)
o PHAR134G Biostatistics
o PHAR165G Drug Information and Introduction to Evidence Based Medicine
Dr. Parihar has strong interest in clinical research, especially in the area of diabetes. The key areas of interest are: 1) medication use in gestational diabetes (GDM): management, therapeutic options/outcomes and maternal and fetal Implications; 2) cost benefit analysis of medication use; and 3) medication adherence along with glycemic monitoring and control in diabetic patients.
1. Parihar, H.S.*,Yin, H., Gooch, J., Allen, S., John, S., Xuan, J. Trends in hospital admissions due to antidepressant-related adverse drug events from 2001 to 2011 in the US. Submitted to BMC-Health Services Research
2. Parihar, H.S.*, Thakar, H., Mody, V., Yin, H., Allen, S. Is depression a risk factor for the onset of type-2 diabetes mellitus? Submitted to Drug Development and Therapeutics
3. Hirsch, A.C., Parihar, H.S., A pharmacy capstone course with a comprehensive and integrated review of the pharmacy curriculum and student assessment as a preparation for advance pharmacy practice experiences, American Journal of Pharmaceutical Education, 2014, 78:10, 192
4. Reece S.W., Parihar, H.S., LoBello, C., Metformin in gestational Diabetes Mellitus, Diabetes Spectrum, 2014, 27:4, 289-295.
5. Parihar, H. S.*, Bacillus cereus, Encyclopedia of Toxicology, Third edition, 2014, 353-354
6. Sawant, S. P., Parihar, H. S., and Mehendale, H. M., Allyl Alcohol, Encyclopedia of Toxicology, Third edition, 2014, 146-148.
7. Sawant, S. P., Parihar, H. S., and Mehendale, H. M., Anabolic Steroids, Encyclopedia of Toxicology, Third edition, 2014, 220-222.
8. Sawant, S. P., Parihar, H. S., and Mehendale, H. M., British Anti-Lewisite (BAL), Encyclopedia of Toxicology, Third edition, 2014, 360-362.
9. Sawant, S.P., Parihar, H.S., Mehendale, H.M., Hanson K., Good Clinical Practice, Encyclopedia of Toxicology, Third edition, 2014, 772-777
10. Mody, V. V., Cox, A., Shah, S., Singh, A., Bevins, W., and Parihar, H. S., Magnetic nanoparticle drug delivery systems for targeting tumor, Applied Nanoscience, 2014, 4:4, 385-392.
11. Shannon, J. A., Ferrara, J. J., Allen, S. N., John, S., and Parihar, H. S., A clinical review of statin-associated myopathy, Journal of Pharmacy Technology, 2013, 29:5: 219-230.
12. Parihar, H. S.; Suryanarayanan, A.; Ma, C.; Joshi, P.; Venkataraman, P.; Schulte, M. K.; Kirschbaum, K. S., 5-HT3R binding of lerisetron: an interdisciplinary approach to drug-receptor interactions, Bioorganic and Medicinal Chemistry Letters, 2001, 11, 2133-2136
13. Parihar, H. S.; Kirschbaum, K. S., Electrostatic potential surfaces of 5-HT3R agonists suggest accessory cation- site adjacent to agonist binding domain, Bioorganic and Medicinal Chemistry Letters, 2002, 12:19, 2743-2747
14. Venkataraman, P.; Joshi, P. R.; Srinivasan, P. V.; Muthalagi, M.; Parihar, H. S.; Kirschbaum K. S.; Schulte M. K., Functional group interactions of a 5-HT3R antagonist, BMC-Biochemistry, 2002, 3:16
15. Schulte, M.K.; Hill, R.A.; Bikádi, Z.; Maksay, G.; Parihar, H. S.; Joshi, P.; Suryanarayanan, A., Biophysical aspects of ligand-gated ion channel receptor superfamilies; Arias, H.R.; Ed., Research Signpost: (NY), 2006, 127-154
2011 – 2014: Chair of the Curriculum Committee of PCOM-SOP
2010 – present: Member of the Curriculum Committee of PCOM-SOP
2010 – 2011: Chair of the Faculty Development Committee of PCOM-SOP
2011 – 2014: Chair of the Student Academic Progress & Policy Committee of PCOM
2010 – 2011: Member of the Student Academic Progress & Policy Committee of PCOM
2010 – 2012: Member of the Academic Performance and Standards Committee (APS) of PCOM-SOP
2010 – present: Faculty Advisor for PharmD students of PCOM-SOP
2010 – present: Member of the Ad-hoc Bylaws committee of PCOM-SOP
2011 – present: Member of the Pharmaceutical Sciences Search Committee of PCOM-SOP
2012: Member of the Faculty Peer Review Team of PCOM-SOP.
2012 – present: Member of the Ad-hoc Curriculum Self-Study committee of PCOM-SOP
2004 – 2013: Executive committee member of the Younger Chemists Committee (YCC) of American Chemical Society (ACS), Washington DC.